Stockreport

Sigyn Therapeutics Issues Shareholder Update Regarding Potential Merger and Asset Sale Initiatives [Yahoo! Finance]

Aethlon Medical, Inc.  (AEMD) 
NASDAQ:AMEX Investor Relations: ir.aethlonmedical.com
PDF therapies to address cardiovascular disease and cancer, today released the following shareholder update authored by Chief Executive Officer, Jim Joyce. Dear Shareholde [Read more]